Teva Pharmaceuticals - Paragard's Unit Acquisition

Teva Pharmaceuticals - Paragard raised a round of funding on September 12, 2017. Investors include The Cooper Companies.

Paragard is a copper-releasing device that is placed in the patient's uterus to prevent pregnancy for up to ten years. The copper in Paragard interferes with sperm movement, egg fertilization, and pos…

Articles about Teva Pharmaceuticals - Paragard's Unit Acquisition: